{"id":"magnesium-aspartate","rwe":[{"pmid":"41221788","year":"2025","title":"Single Center, Open-Label, Randomized Crossover Trial on Drug-Drug Interactions of Levothyroxine/Magnesium-Citrate and Levothyroxine/Magnesium-Aspartate in Healthy Subjects-The ThyroMag Trial.","finding":"","journal":"Clinical and translational science","studyType":"Clinical Study"},{"pmid":"39792715","year":"2025","title":"Gitelman syndrome with diabetes and kidney stones: A case report.","finding":"","journal":"Medicine","studyType":"Clinical Study"},{"pmid":"39062445","year":"2024","title":"In Males with Adequate Dietary Needs Who Present No Sleep Disturbances, Is an Acute Intake of Zinc Magnesium Aspartate, Following Either Two Consecutive Nights of 8 or 4 h of Sleep Deprivation, Beneficial for Sleep and Morning Stroop Interference Performance?","finding":"","journal":"Behavioral sciences (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"38639324","year":"2024","title":"Verifying the nonreporting hemolysis index for potassium, phosphate, magnesium, AST, LDH, iron, CA 19-9, and vitamin D, using Beckman Coulter AU5800 and DxI800 automated analyzers.","finding":"","journal":"Laboratory medicine","studyType":"Clinical Study"},{"pmid":"38608089","year":"2024","title":"Clinical and genetic analysis of a case of Gitelman syndrome accompanied with Graves disease and adrenocortical adenoma: A case report.","finding":"","journal":"Medicine","studyType":"Clinical Study"}],"tags":[{"label":"magnesium aspartate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"A12CC05","category":"atc"},{"label":"Oral","category":"route"},{"label":"Capsule","category":"form"},{"label":"Active","category":"status"},{"label":"Constipation","category":"indication"},{"label":"Hypokalemia","category":"indication"},{"label":"Hypokalemia Prevention","category":"indication"},{"label":"Hypomagnesemia","category":"indication"},{"label":"Incomplete passage of stool","category":"indication"},{"label":"Indigestion","category":"indication"}],"phase":"unknown","safety":{"safetySignals":[{"llr":86.24,"date":"","count":18,"signal":"Fractional exhaled nitric oxide increased","source":"DrugCentral FAERS","actionTaken":"Reported 18 times (LLR=86)"},{"llr":70.517,"date":"","count":18,"signal":"Infective exacerbation of chronic obstructive airways disease","source":"DrugCentral FAERS","actionTaken":"Reported 18 times (LLR=71)"},{"llr":68.602,"date":"","count":19,"signal":"Listless","source":"DrugCentral FAERS","actionTaken":"Reported 19 times (LLR=69)"},{"llr":63.393,"date":"","count":18,"signal":"Myoglobin blood increased","source":"DrugCentral FAERS","actionTaken":"Reported 18 times (LLR=63)"},{"llr":61.407,"date":"","count":16,"signal":"Reduced facial expression","source":"DrugCentral FAERS","actionTaken":"Reported 16 times (LLR=61)"},{"llr":58.034,"date":"","count":18,"signal":"Plantar fasciitis","source":"DrugCentral FAERS","actionTaken":"Reported 18 times (LLR=58)"},{"llr":53.775,"date":"","count":18,"signal":"Sensation of foreign body","source":"DrugCentral FAERS","actionTaken":"Reported 18 times (LLR=54)"},{"llr":49.91,"date":"","count":9,"signal":"Nerve degeneration","source":"DrugCentral FAERS","actionTaken":"Reported 9 times (LLR=50)"},{"llr":49.077,"date":"","count":29,"signal":"Hypomagnesaemia","source":"DrugCentral FAERS","actionTaken":"Reported 29 times (LLR=49)"},{"llr":48.886,"date":"","count":11,"signal":"Reflexes abnormal","source":"DrugCentral FAERS","actionTaken":"Reported 11 times (LLR=49)"},{"llr":48.569,"date":"","count":18,"signal":"Brain natriuretic peptide increased","source":"DrugCentral FAERS","actionTaken":"Reported 18 times (LLR=49)"},{"llr":45.498,"date":"","count":19,"signal":"Apathy","source":"DrugCentral FAERS","actionTaken":"Reported 19 times (LLR=45)"},{"llr":42.7,"date":"","count":20,"signal":"Head discomfort","source":"DrugCentral FAERS","actionTaken":"Reported 20 times (LLR=43)"},{"llr":37.709,"date":"","count":48,"signal":"Atrial fibrillation","source":"DrugCentral FAERS","actionTaken":"Reported 48 times (LLR=38)"},{"llr":36.369,"date":"","count":16,"signal":"Affect lability","source":"DrugCentral FAERS","actionTaken":"Reported 16 times (LLR=36)"}],"commonSideEffects":[{"effect":"Fractional exhaled nitric oxide increased","drugRate":"LLR 86","severity":"common"},{"effect":"Infective exacerbation of chronic obstructive airways disease","drugRate":"LLR 71","severity":"common"},{"effect":"Listless","drugRate":"LLR 69","severity":"common"},{"effect":"Myoglobin blood increased","drugRate":"LLR 63","severity":"common"},{"effect":"Reduced facial expression","drugRate":"LLR 61","severity":"common"},{"effect":"Plantar fasciitis","drugRate":"LLR 58","severity":"common"},{"effect":"Sensation of foreign body","drugRate":"LLR 54","severity":"common"},{"effect":"Nerve degeneration","drugRate":"LLR 50","severity":"common"},{"effect":"Hypomagnesaemia","drugRate":"LLR 49","severity":"common"},{"effect":"Reflexes abnormal","drugRate":"LLR 49","severity":"common"},{"effect":"Brain natriuretic peptide increased","drugRate":"LLR 49","severity":"common"},{"effect":"Apathy","drugRate":"LLR 45","severity":"common"},{"effect":"Head discomfort","drugRate":"LLR 43","severity":"common"},{"effect":"Atrial fibrillation","drugRate":"LLR 38","severity":"common"},{"effect":"Affect lability","drugRate":"LLR 36","severity":"common"}],"contraindications":["Acute nephropathy","Chronic diarrhea","Complete atrioventricular block","Congenital myotonia, autosomal dominant form","Diarrhea","Familial hyperkalemic periodic paralysis","Gastrointestinal obstruction","Gastrointestinal ulcer","Gastroparesis","Hyperkalemia","Hyporeninemic hypoaldosteronism","Kidney disease","Severe dehydration"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"magnesium hydroaspartate","offLabel":[],"synonyms":["magnesium aspartate","Aspartic Acid, Magnesium (2:1) Salt","magnesium hydroaspartate"],"timeline":[],"approvals":[],"brandName":"Magnesium Hydroaspartate","ecosystem":[{"indication":"Constipation","otherDrugs":[{"name":"bisacodyl","slug":"bisacodyl","company":"Braintree"},{"name":"cholic acid","slug":"cholic-acid","company":"Rtrx"},{"name":"docusate sodium","slug":"docusate-sodium","company":""},{"name":"glycerol","slug":"glycerol","company":"B Braun"}],"globalPrevalence":1120000000},{"indication":"Hypokalemia","otherDrugs":[{"name":"aspartic acid","slug":"aspartic-acid","company":""},{"name":"calcium chloride","slug":"calcium-chloride","company":"Baxter Hlthcare"},{"name":"potassium acetate","slug":"potassium-acetate","company":"B Braun"},{"name":"potassium chloride","slug":"potassium-chloride","company":"Hospira"}],"globalPrevalence":null},{"indication":"Hypokalemia Prevention","otherDrugs":[{"name":"amiloride","slug":"amiloride","company":"Paddock Llc"},{"name":"aspartic acid","slug":"aspartic-acid","company":""},{"name":"calcium chloride","slug":"calcium-chloride","company":"Baxter Hlthcare"},{"name":"potassium acetate","slug":"potassium-acetate","company":"B Braun"}],"globalPrevalence":null},{"indication":"Hypomagnesemia","otherDrugs":[{"name":"magnesium carbonate","slug":"magnesium-carbonate","company":"United Guardian"},{"name":"magnesium chloride","slug":"magnesium-chloride","company":"Hospira"},{"name":"magnesium oxide","slug":"magnesium-oxide","company":"Baxter Hlthcare"},{"name":"magnesium sulfate","slug":"magnesium-sulfate","company":"Baxter Hlthcare"}],"globalPrevalence":null},{"indication":"Incomplete passage of stool","otherDrugs":[{"name":"bisacodyl","slug":"bisacodyl","company":"Braintree"},{"name":"cholic acid","slug":"cholic-acid","company":"Rtrx"},{"name":"homatropine","slug":"homatropine","company":""},{"name":"macrogol","slug":"macrogol","company":"Braintree"}],"globalPrevalence":null},{"indication":"Indigestion","otherDrugs":[{"name":"algeldrate","slug":"algeldrate","company":"Sanofi Aventis Us"},{"name":"almasilate","slug":"almasilate","company":""},{"name":"bismuth subsalicylate","slug":"bismuth-subsalicylate","company":"Prometheus Labs"},{"name":"calcium carbonate","slug":"calcium-carbonate","company":"Mcneil Cons"}],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","drugClass":"magnesium aspartate","explanation":"Think of it like a key that unlocks the muscles in your digestive tract. When you have enough magnesium, your muscles can relax and let food pass through more easily. This helps to prevent constipation and other gastrointestinal problems.","oneSentence":"Magnesium Hydroaspartate works by replenishing magnesium levels in the body, which helps to relax muscles and improve bowel function.","technicalDetail":"Magnesium Hydroaspartate acts as a magnesium ion donor, increasing the concentration of magnesium ions in the body. This helps to activate various cellular processes, including muscle relaxation and nerve function, which are essential for normal bowel function."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Magnesium_aspartate","title":"Magnesium aspartate","extract":"Magnesium aspartate is a magnesium salt of L-aspartic acid, an amino acid, with the chemical formula Mg(C4H6NO4)2(H2O)2. It is used as a mineral supplement, and as an ingredient in manufacturing of cosmetics and household products."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4517","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=magnesium%20aspartate","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=magnesium aspartate","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Magnesium_aspartate","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T14:12:37.348925","biosimilars":[],"competitors":[{"drugName":"magnesium chloride","drugSlug":"magnesium-chloride","fdaApproval":"1975-08-13","relationship":"same-class"},{"drugName":"magnesium sulfate","drugSlug":"magnesium-sulfate","fdaApproval":"1981-10-06","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"magnesium citrate","drugSlug":"magnesium-citrate","fdaApproval":"","relationship":"same-class"},{"drugName":"magnesium oxide","drugSlug":"magnesium-oxide","fdaApproval":"1982-06-22","relationship":"same-class"}],"genericName":"magnesium aspartate","indications":{"approved":[{"name":"Constipation","source":"DrugCentral","snomedId":14760008,"regulator":"FDA","usPrevalence":null,"globalPrevalence":1120000000,"prevalenceMethod":"curated","prevalenceSource":"Am J Gastroenterol, 2011 (PMID:21606976)"},{"name":"Hypokalemia","source":"DrugCentral","snomedId":43339004,"regulator":"FDA"},{"name":"Hypokalemia Prevention","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Hypomagnesemia","source":"DrugCentral","snomedId":190855004,"regulator":"FDA"},{"name":"Incomplete passage of stool","source":"DrugCentral","snomedId":249515001,"regulator":"FDA"},{"name":"Indigestion","source":"DrugCentral","snomedId":162031009,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"magnesium-chloride","brandName":"magnesium chloride","genericName":"magnesium chloride","approvalYear":"1975","relationship":"same-class"},{"drugId":"magnesium-sulfate","brandName":"magnesium sulfate","genericName":"magnesium sulfate","approvalYear":"1981","relationship":"same-class"},{"drugId":"magnesium-citrate","brandName":"magnesium citrate","genericName":"magnesium citrate","approvalYear":"","relationship":"same-class"},{"drugId":"magnesium-oxide","brandName":"magnesium oxide","genericName":"magnesium oxide","approvalYear":"1982","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07149649","phase":"PHASE2,PHASE3","title":"Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)","status":"NOT_YET_RECRUITING","sponsor":"Swiss Cancer Institute","startDate":"2026-07","conditions":["Metastatic NSCLC - Non-Small Cell Lung Cancer"],"enrollment":230,"completionDate":"2035-03-31"},{"nctId":"NCT06867068","phase":"PHASE1","title":"Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2016-10-04","conditions":["Anesthesia","Tooth Extraction"],"enrollment":73,"completionDate":"2024-06-10"},{"nctId":"NCT02543983","phase":"PHASE2","title":"Neurobiology of Suicide","status":"RECRUITING","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2015-12-01","conditions":["Healthy Volunteers","Depression"],"enrollment":325,"completionDate":"2030-07-21"},{"nctId":"NCT06547489","phase":"PHASE2","title":"Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder","status":"RECRUITING","sponsor":"Syndeio Biosciences, Inc","startDate":"2025-02-03","conditions":["Major Depressive Disorder"],"enrollment":164,"completionDate":"2027-12"},{"nctId":"NCT07099989","phase":"PHASE1","title":"Pharmacokinetics of Zelquistinel in Fasted or Fed State","status":"ACTIVE_NOT_RECRUITING","sponsor":"Syndeio Biosciences, Inc","startDate":"2025-07-24","conditions":["Healthy Volunteers in Fed and Fasted State"],"enrollment":32,"completionDate":"2026-07"},{"nctId":"NCT07115329","phase":"PHASE2","title":"A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder","status":"RECRUITING","sponsor":"Syndeio Biosciences, Inc","startDate":"2026-01-05","conditions":["Major Depressive Disorder"],"enrollment":164,"completionDate":"2028-06"},{"nctId":"NCT05042245","phase":"PHASE4","title":"The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules","status":"COMPLETED","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2019-07-23","conditions":["Non-alcoholic Fatty Liver Disease"],"enrollment":237,"completionDate":"2022-12-20"},{"nctId":"NCT04953910","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment","status":"RECRUITING","sponsor":"Taiho Oncology, Inc.","startDate":"2022-12-23","conditions":["Acute Myeloid Leukemia","Myelodysplastic Syndromes"],"enrollment":27,"completionDate":"2026-12"},{"nctId":"NCT07442552","phase":"","title":"Perioperative Sepsis. An Epigenetic Perspective","status":"RECRUITING","sponsor":"Carol Davila University of Medicine and Pharmacy","startDate":"2026-01-20","conditions":["Sepsis Abdominal"],"enrollment":40,"completionDate":"2026-04-10"},{"nctId":"NCT06575153","phase":"PHASE1","title":"Phase 1 Study of ART5803 in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arialys Therapeutics","startDate":"2024-09-19","conditions":["Autoimmune Encephalitis"],"enrollment":64,"completionDate":"2026-03-11"},{"nctId":"NCT07377786","phase":"","title":"Study of Prognostic Values of Platelet Indices and Inflammatory Markers in Patients With HELLP Syndrome.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-02-01","conditions":["HELLP Syndrome"],"enrollment":60,"completionDate":"2026-12"},{"nctId":"NCT07377032","phase":"PHASE3","title":"TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders","status":"RECRUITING","sponsor":"Meyer Children's Hospital IRCCS","startDate":"2025-08-29","conditions":["GRIN-related Disorders","GRIN1","GRIN2A","GRIN2B","GRIN2D","Epilepsy","Neurodevelopmental Disorder (Diagnosis)"],"enrollment":40,"completionDate":"2028-06"},{"nctId":"NCT06114498","phase":"","title":"Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Medical Research Center for Therapy and Preventive Medicine","startDate":"2023-09-01","conditions":["Heart Failure With Preserved Ejection Fraction","Obesity, Mild","Decompensated Heart Failure"],"enrollment":240,"completionDate":"2026-07-31"},{"nctId":"NCT07360405","phase":"NA","title":"Dietary Intervention for Migraine Relief","status":"NOT_YET_RECRUITING","sponsor":"American University","startDate":"2026-01","conditions":["Migraine"],"enrollment":40,"completionDate":"2027-03"},{"nctId":"NCT03065335","phase":"PHASE1","title":"Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder","status":"RECRUITING","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2017-05-25","conditions":["Healthy Volunteer","Major Depressive Disorder","Depression"],"enrollment":150,"completionDate":"2028-01-01"},{"nctId":"NCT05569759","phase":"PHASE2","title":"A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)","status":"COMPLETED","sponsor":"Kezar Life Sciences, Inc.","startDate":"2023-05-23","conditions":["Autoimmune Hepatitis"],"enrollment":24,"completionDate":"2025-04-30"},{"nctId":"NCT07334223","phase":"NA","title":"Comparison of Intravenous Ondansetron and Low Dose Ketamine in Preventing Post Spinal Shivering","status":"COMPLETED","sponsor":"Mayo Hospital Lahore","startDate":"2020-01-01","conditions":["Postoperative Shivering","Postspinal Shivering"],"enrollment":180,"completionDate":"2020-06-30"},{"nctId":"NCT07310524","phase":"NA","title":"COMPARISON OF OPIOID-FREE AND OPIOID-BASED ANESTHESIA TECHNIQUES ON qNOX INDEX IN ABDOMINAL SURGERY UNDER GENERAL ANESTHESIA","status":"COMPLETED","sponsor":"Muhammad Rahman Efendi Nasution","startDate":"2025-09-08","conditions":["Opioid-free Anesthesia"],"enrollment":42,"completionDate":"2025-12-01"},{"nctId":"NCT03736538","phase":"PHASE1","title":"Nitrous Oxide- Suicidal Ideation","status":"ENROLLING_BY_INVITATION","sponsor":"Washington University School of Medicine","startDate":"2018-10-30","conditions":["Major Depressive Disorder","Depression","Mood Disorders","Suicidal Ideation"],"enrollment":50,"completionDate":"2026-12"},{"nctId":"NCT06309277","phase":"PHASE2","title":"A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD","status":"COMPLETED","sponsor":"Gilgamesh Pharmaceuticals","startDate":"2024-02-01","conditions":["Major Depressive Disorder"],"enrollment":46,"completionDate":"2025-03-27"},{"nctId":"NCT07117630","phase":"PHASE2","title":"An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-09-25","conditions":["Breast Cancer"],"enrollment":20,"completionDate":"2027-08"},{"nctId":"NCT04398680","phase":"PHASE1","title":"A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2021-04-20","conditions":["Multiple Myeloma"],"enrollment":0,"completionDate":"2025-11-04"},{"nctId":"NCT06944275","phase":"","title":"Characterising the Loss of Haemostasis in Haemorrhagic Fever With Renal Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Liverpool School of Tropical Medicine","startDate":"2026-05-01","conditions":["Haemorrhagic Fever With Renal Syndrome"],"enrollment":62,"completionDate":"2027-08-31"},{"nctId":"NCT06592014","phase":"PHASE1,PHASE2","title":"Lithium for Parkinson's: an Extension Trial","status":"ENROLLING_BY_INVITATION","sponsor":"State University of New York at Buffalo","startDate":"2024-08-09","conditions":["Parkinson Disease"],"enrollment":35,"completionDate":"2026-11-01"},{"nctId":"NCT07211841","phase":"NA","title":"Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM)","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2025-12","conditions":["Glioblastoma","MRI Spectroscopy","Tumor Microenvironment","Biomarkers / Blood"],"enrollment":30,"completionDate":"2029-04"},{"nctId":"NCT04833907","phase":"PHASE1,PHASE2","title":"rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Myrtelle Inc.","startDate":"2021-04-01","conditions":["Canavan Disease"],"enrollment":24,"completionDate":"2027-08-31"},{"nctId":"NCT06789757","phase":"PHASE2","title":"The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)","status":"RECRUITING","sponsor":"Inova Health Care Services","startDate":"2025-02-25","conditions":["Hepatocellular Carcinoma"],"enrollment":19,"completionDate":"2028-01-27"},{"nctId":"NCT06284473","phase":"PHASE4","title":"Ketamine as a Supplement to Local Anesthesia for Minor Procedures","status":"RECRUITING","sponsor":"Loyola University","startDate":"2022-05-25","conditions":["Pain, Procedural","Minor Laceration","Abscess"],"enrollment":108,"completionDate":"2028-05-31"},{"nctId":"NCT05400733","phase":"NA","title":"Prandial Metabolic Phenotype in Adults","status":"RECRUITING","sponsor":"Texas A&M University","startDate":"2022-06-24","conditions":["Protein Metabolism"],"enrollment":50,"completionDate":"2026-09"},{"nctId":"NCT06753955","phase":"PHASE1","title":"Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arialys Therapeutics","startDate":"2025-03-18","conditions":["Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody","Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)","Autoimmune Encephalitis"],"enrollment":6,"completionDate":"2025-12-24"},{"nctId":"NCT05619692","phase":"PHASE2","title":"A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)","status":"COMPLETED","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2022-11-29","conditions":["Mild Cognitive Impairment","Mild Dementia","Alzheimer's Disease"],"enrollment":174,"completionDate":"2024-07-09"},{"nctId":"NCT07167251","phase":"","title":"Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-08-25","conditions":["Immune Related Adverse Events","Immune-Mediated Hepatitis","Cancer"],"enrollment":63,"completionDate":"2026-12-31"},{"nctId":"NCT06003400","phase":"NA","title":"Proof of Concept Open Label, Clinical Trial to Evaluate the Safety and Efficacy of the \"FITT\" Device in Diabetic Foot Ulcers Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tri.O Medical LTD","startDate":"2023-03-29","conditions":["Diabetic Foot Ulcer"],"enrollment":20,"completionDate":"2026-01"},{"nctId":"NCT06737380","phase":"PHASE1","title":"UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients","status":"RECRUITING","sponsor":"LiveKidney.Bio","startDate":"2025-01-07","conditions":["SLE","Lupus","Systemic Lupus Erthematosus","Systemic Lupus Erythematosus","Systemic Lupus Erythematosus (SLE)"],"enrollment":10,"completionDate":"2026-07"},{"nctId":"NCT05045378","phase":"PHASE4","title":"Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2022-03-15","conditions":["Treatment-resistant Depression","Major Depressive Disorder"],"enrollment":12,"completionDate":"2024-11-30"},{"nctId":"NCT07144501","phase":"NA","title":"Prevalence of Liver Dysfunction in Pediatric Patients With Congenital Heart Disease at Assiut.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-09-15","conditions":["Congenital Heart Disease","Liver Dysfunction"],"enrollment":40,"completionDate":"2026-03-15"},{"nctId":"NCT06483737","phase":"NA","title":"Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-06-24","conditions":["Overt Hepatic Encephalopathy"],"enrollment":174,"completionDate":"2027-06-30"},{"nctId":"NCT06099886","phase":"PHASE1","title":"Repurposing Lithium for Parkinson's Disease","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2023-10-12","conditions":["Parkinson's Disease"],"enrollment":17,"completionDate":"2025-04-30"},{"nctId":"NCT06810765","phase":"PHASE2","title":"Trifecta Research Study","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2025-09","conditions":["PTSD - Post Traumatic Stress Disorder","Cognitive Dysfunction","Brain Trauma","Brain Injuries"],"enrollment":0,"completionDate":"2027-12"},{"nctId":"NCT06387667","phase":"NA","title":"Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections","status":"NOT_YET_RECRUITING","sponsor":"New Valley University","startDate":"2025-12-01","conditions":["Immunocompromised ICU Patients With Respiratory Tract Infections"],"enrollment":250,"completionDate":"2027-06-01"},{"nctId":"NCT07093333","phase":"PHASE2","title":"A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Antibody-Associated Psychiatric Disease","status":"NOT_YET_RECRUITING","sponsor":"Arialys Australia Pty Ltd","startDate":"2025-08-01","conditions":["Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE)","Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease","Autoimmune Encephalitis"],"enrollment":30,"completionDate":"2027-03-30"},{"nctId":"NCT06620835","phase":"PHASE2","title":"Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib","status":"RECRUITING","sponsor":"Groupe Francais De Pneumo-Cancerologie","startDate":"2025-06-19","conditions":["NSCLC"],"enrollment":45,"completionDate":"2030-10-01"},{"nctId":"NCT06867991","phase":"PHASE3","title":"Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis","status":"RECRUITING","sponsor":"The First People's Hospital of Changzhou","startDate":"2024-11-08","conditions":["Anti-N-Methyl-D-Aspartate Receptor Encephalitis"],"enrollment":200,"completionDate":"2027-11-08"},{"nctId":"NCT03794362","phase":"","title":"Measuring Analgesic Interventions","status":"RECRUITING","sponsor":"Julia Finkel","startDate":"2018-10-29","conditions":["Pain"],"enrollment":120,"completionDate":"2025-12"},{"nctId":"NCT07037394","phase":"PHASE4","title":"A Trial for Comparing Rifaximin, Probiotic and L-ornithine- L Aspartate With Lactulose in Overt Hepatic Encephalopathy.","status":"COMPLETED","sponsor":"Qurratul Ain Jamil","startDate":"2024-12-02","conditions":["Overt Hepatic Encephalopathy"],"enrollment":252,"completionDate":"2025-04-30"},{"nctId":"NCT07023159","phase":"","title":"Predicting 28-Day Survival in OHCA Patients","status":"COMPLETED","sponsor":"Haseki Training and Research Hospital","startDate":"2023-05-01","conditions":["Out of Hospital Cardiac Arrest","Cardiac Arrest (CA)"],"enrollment":327,"completionDate":"2024-06-01"},{"nctId":"NCT01808352","phase":"","title":"HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)","status":"COMPLETED","sponsor":"HIV Prevention Trials Network","startDate":"2013-08-15","conditions":["HIV"],"enrollment":226,"completionDate":"2015-09-30"},{"nctId":"NCT06910098","phase":"NA","title":"Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels","status":"COMPLETED","sponsor":"Central Park Medical College","startDate":"2023-12-01","conditions":["LDL - Low Density Lipoprotein Receptor Disorder","Rosuvastatin"],"enrollment":195,"completionDate":"2024-08-31"},{"nctId":"NCT05565352","phase":"","title":"Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)","status":"ENROLLING_BY_INVITATION","sponsor":"Medical University of Gdansk","startDate":"2022-09-01","conditions":["Major Depressive Disorder","Post Traumatic Stress Disorder","Obsessive-Compulsive Disorder","Somatoform Disorders","Anxiety Disorders","Dissociative Disorder"],"enrollment":140,"completionDate":"2029-12-31"},{"nctId":"NCT05786599","phase":"PHASE2,PHASE3","title":"Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-03-21","conditions":["Chemotherapy-induced Peripheral Neuropathy"],"enrollment":50,"completionDate":"2026-03"},{"nctId":"NCT04101474","phase":"NA","title":"Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality","status":"COMPLETED","sponsor":"Assiut University","startDate":"2020-09-01","conditions":["Treatment Resistant Depression"],"enrollment":36,"completionDate":"2021-10-01"},{"nctId":"NCT04964310","phase":"","title":"Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2020-08-31","conditions":["Acetaminophen","Drug-Induced Liver Injury","Pharmacogenetics","China"],"enrollment":339,"completionDate":"2026-12-31"},{"nctId":"NCT06818149","phase":"","title":"Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer","status":"RECRUITING","sponsor":"Shanghai Chest Hospital","startDate":"2025-01-30","conditions":["Lung Cancer","Myocarditis Due to Drug"],"enrollment":50,"completionDate":"2028-12-30"},{"nctId":"NCT05737030","phase":"PHASE4","title":"Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of Graz","startDate":"2023-02-06","conditions":["Cirrhosis"],"enrollment":55,"completionDate":"2025-12"},{"nctId":"NCT05177146","phase":"NA","title":"Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2022-05-04","conditions":["Bipolar Disorder (BD)","Suicidality"],"enrollment":16,"completionDate":"2025-01-10"},{"nctId":"NCT05435638","phase":"PHASE1","title":"Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases","status":"COMPLETED","sponsor":"Kamari Pharma Ltd","startDate":"2022-07-17","conditions":["Punctate Palmoplantar Keratoderma Type 1","Pachyonychia Congenita"],"enrollment":14,"completionDate":"2024-09-05"},{"nctId":"NCT04932512","phase":"PHASE2","title":"A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224","status":"COMPLETED","sponsor":"Ionis Pharmaceuticals, Inc.","startDate":"2021-06-17","conditions":["Steatohepatitis, Nonalcoholic"],"enrollment":160,"completionDate":"2024-02-28"},{"nctId":"NCT05539027","phase":"PHASE4","title":"Efficacy of L-Ornithine L-Aspartate (LOLA) as an Adjunct to Branched Chain Amino Acids (BCAA) Enriched Solutions on Clinical Outcomes in ICU Patients With Hepatic Encephalopathy","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-09-20","conditions":["Hepatic Encephalopathy"],"enrollment":140,"completionDate":"2024-10-31"},{"nctId":"NCT06108297","phase":"PHASE1","title":"Lithium Long COVID Dose-finding Study","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2023-10-12","conditions":["Long COVID"],"enrollment":5,"completionDate":"2024-05-02"},{"nctId":"NCT04513288","phase":"NA","title":"ICITRU : Randomized Trial of Immunonutrition With L-citrulline in Patients Hospitalized in Intensive Care for Sepsis or Septic Shock","status":"RECRUITING","sponsor":"Rennes University Hospital","startDate":"2022-05-20","conditions":["Sepsis","Septic Shock"],"enrollment":130,"completionDate":"2026-11-20"},{"nctId":"NCT05218356","phase":"PHASE2","title":"Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19","status":"RECRUITING","sponsor":"Code Pharma","startDate":"2022-01-20","conditions":["COVID-19"],"enrollment":130,"completionDate":"2025-07-20"},{"nctId":"NCT06506643","phase":"PHASE1,PHASE2","title":"Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms","status":"RECRUITING","sponsor":"Vector Vitale LLC","startDate":"2024-05-15","conditions":["CLL","Solid Tumor, Adult"],"enrollment":36,"completionDate":"2026-10-31"},{"nctId":"NCT04546360","phase":"","title":"Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)","status":"COMPLETED","sponsor":"Hepatopancreatobiliary Surgery Institute of Gansu Province","startDate":"2020-09-08","conditions":["Compensated Advanced Chronic Liver Disease","Variceal Hemorrhage"],"enrollment":381,"completionDate":"2022-12-31"},{"nctId":"NCT04209296","phase":"","title":"Chart Review of Patients Undergoing Ketamine Infusions","status":"COMPLETED","sponsor":"Brain and Cognition Discovery Foundation","startDate":"2019-12-03","conditions":["Major Depressive Disorder","Bipolar Disorder","Obsessive-Compulsive Disorder","Post Traumatic Stress Disorder"],"enrollment":891,"completionDate":"2023-09-14"},{"nctId":"NCT06337994","phase":"PHASE3","title":"Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury","status":"COMPLETED","sponsor":"Assiut University","startDate":"2024-01-01","conditions":["Treatment of Cognitive Deficits After Traumatic Brain Injury"],"enrollment":60,"completionDate":"2024-08-01"},{"nctId":"NCT03809442","phase":"PHASE4","title":"Analgesic Efficacy of Ropivacaine Alone or in Combination With Adjuvants on Post-operative Analgesia Following Video-Assisted Thoracoscopic Surgery.","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2019-06-25","conditions":["Postoperative Analgesia"],"enrollment":116,"completionDate":"2023-08-31"},{"nctId":"NCT06435130","phase":"NA","title":"The Impact of Chokeberry Bioproducts on Metabolic Parameters and Antioxidant Potential","status":"COMPLETED","sponsor":"Medical University of Bialystok","startDate":"2022-05-01","conditions":["Diet, Healthy","Diabetes Mellitus","Hypertension","Obesity","Hypercholesterolemia"],"enrollment":102,"completionDate":"2022-08-30"},{"nctId":"NCT06403553","phase":"","title":"FC Change From Day 1 to Day 3 Associated With SALD","status":"COMPLETED","sponsor":"Chinese Medical Association","startDate":"2023-01-01","conditions":["Liver Dysfunction"],"enrollment":96,"completionDate":"2024-03-31"},{"nctId":"NCT06306040","phase":"PHASE3","title":"Effect of Intravenous Nalbuphine and Magnesium Sulfate on Emergence Agitation in Pediatric","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-04-02","conditions":["Emergence Delirium"],"enrollment":105,"completionDate":"2025-01-30"},{"nctId":"NCT06299800","phase":"","title":"Phenotyping Patients With Type 2 Diabetes Mellitus and Cancer","status":"RECRUITING","sponsor":"Azienda Ospedaliero Universitaria Maggiore della Carita","startDate":"2024-02-04","conditions":["Diabetes Mellitus, Type 2","Cancer"],"enrollment":779,"completionDate":"2025-02-04"},{"nctId":"NCT06296004","phase":"","title":"Relation Between Nail Fold Capillaroscopy, Optical Coherence Tomography Angiography, and Femoral Vein Wall Thickness in Behçet's Disease Relation Between Nail Fold Capillaroscopy, Optical Coherence Tomography Angiography, and Femoral Vein Wall Thickness in Behçet's Disease","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-03-01","conditions":["Behçet's Disease"],"enrollment":80,"completionDate":"2025-04-01"},{"nctId":"NCT06287125","phase":"","title":"Renal Assessment for Early Detection of Renal Impairment in Systemic Sclerosis and Systemic Lupus Erythematosus Patients","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-03-01","conditions":["Systemic Sclerosis and Systemic Lupus Erythematous"],"enrollment":95,"completionDate":"2027-03-01"},{"nctId":"NCT03941288","phase":"PHASE2","title":"Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2019-09-04","conditions":["Gastroparesis","Dyspepsia"],"enrollment":92,"completionDate":"2023-02-23"},{"nctId":"NCT06240468","phase":"","title":"Dynamic Changes in Human Microbiome Predict the Risk of Adverse Outcomes in Patients With Acute Ischemic Stroke: a Multicenter Prospective Cohort Study","status":"UNKNOWN","sponsor":"Zhujiang Hospital","startDate":"2022-02-10","conditions":["Acute Ischemic Stroke"],"enrollment":2000,"completionDate":"2025-12-30"},{"nctId":"NCT01721798","phase":"NA","title":"Comparison of Two Intrauterine Devices (IUDs) Among Cape Town HIV-positive Women","status":"COMPLETED","sponsor":"FHI 360","startDate":"2013-11-10","conditions":["HIV"],"enrollment":199,"completionDate":"2018-07-13"},{"nctId":"NCT06212765","phase":"PHASE3","title":"Oral Citrulline Supplementation in COPD Patients With Malnutrition","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Grenoble","startDate":"2024-01-25","conditions":["Chronic Obstructive Pulmonary Disease Severe","Malnutrition"],"enrollment":60,"completionDate":"2026-09-25"},{"nctId":"NCT05101265","phase":"PHASE1","title":"Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment","status":"UNKNOWN","sponsor":"PharmaMar","startDate":"2021-03-09","conditions":["Advanced Solid Tumor","Hepatic Impairment"],"enrollment":24,"completionDate":"2025-06-01"},{"nctId":"NCT04912115","phase":"PHASE2","title":"Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia","status":"SUSPENDED","sponsor":"PharmaTher Inc.","startDate":"2021-10-05","conditions":["Dyskinesias","Movement Disorders","Central Nervous System Diseases","Nervous System Diseases","Neurologic Manifestations"],"enrollment":30,"completionDate":"2024-03-30"},{"nctId":"NCT06119802","phase":"","title":"Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial Fibrillation","status":"UNKNOWN","sponsor":"Yinglong Hou","startDate":"2022-01-01","conditions":["Atrial Fibrillation","Hyperuricemia"],"enrollment":10000,"completionDate":"2024-04-30"},{"nctId":"NCT06077539","phase":"PHASE1,PHASE2","title":"Dexmedetomidine Versus Ketamine Versus Magnesium Sulfate for the Prevention of Emergence Agitation Following Sevoflurane Induced Anesthesia in Cardiac Catheterization in Pediatrics","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-09-20","conditions":["Anesthesia Emergence Delirium"],"enrollment":100,"completionDate":"2024-05-01"},{"nctId":"NCT06042816","phase":"NA","title":"Analgesic Efficacy of Free-opioid Anesthesia for Colorectal Surgery","status":"COMPLETED","sponsor":"Vietnam Military Medical University","startDate":"2019-12-30","conditions":["Colorectal Cancer"],"enrollment":49,"completionDate":"2021-12-30"},{"nctId":"NCT01452503","phase":"NA","title":"Assessing Preference for 3 Female Condoms: A Comparative Evaluation of the PATH Woman's Condom, FC2 and the Reddy 6","status":"COMPLETED","sponsor":"FHI 360","startDate":"2007-05","conditions":["Contraception"],"enrollment":170,"completionDate":"2008-04"},{"nctId":"NCT05999331","phase":"","title":"Elevated Initial APRI Value Was Associated With SALD","status":"UNKNOWN","sponsor":"Chinese Medical Association","startDate":"2019-01-01","conditions":["Liver Dysfunction","Sepsis-associated Liver Dysfunction"],"enrollment":160,"completionDate":"2023-09-30"},{"nctId":"NCT04273932","phase":"PHASE1","title":"Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease.","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2019-10-17","conditions":["Parkinson Disease"],"enrollment":19,"completionDate":"2023-08-12"},{"nctId":"NCT05137938","phase":"NA","title":"Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2021-10-25","conditions":["Depression"],"enrollment":25,"completionDate":"2023-07-24"},{"nctId":"NCT04669509","phase":"","title":"Effect of Liver Injury on Mortality in Coronavirus Disease-2019 Patients Admitted to Intensive Care Unit","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital","startDate":"2020-04-01","conditions":["Covid19; Liver Injury; Mortality"],"enrollment":532,"completionDate":"2020-12-14"},{"nctId":"NCT05920213","phase":"PHASE4","title":"Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy","status":"UNKNOWN","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2023-10","conditions":["Hepatic Encephalopathy Stage 2","Hepatic Encephalopathy Stage 3","Hepatic Encephalopathy Stage 4"],"enrollment":360,"completionDate":"2024-04"},{"nctId":"NCT03612973","phase":"NA","title":"Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-06-01","conditions":["Chronic Hepatitis c"],"enrollment":80,"completionDate":"2022-09-30"},{"nctId":"NCT05880732","phase":"NA","title":"Magnesium Sulfate on Postoperative Pain","status":"COMPLETED","sponsor":"Pamukkale University","startDate":"2021-01-01","conditions":["Postoperative Pain"],"enrollment":68,"completionDate":"2022-03-01"},{"nctId":"NCT05876741","phase":"","title":"Validation of Prognostic Accuracy of ABC ( Age, Blood Urea Nitrogen , Co-morbidities ) and Horibe Pre-endoscopy Scoring Systems in Patients With Upper Gastrointestinal Bleeding in Sohag University Hospital .","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2023-02-15","conditions":["Upper GI Bleeding"],"enrollment":100,"completionDate":"2024-03-15"},{"nctId":"NCT05843812","phase":"","title":"Magnesium Sulfate in Bariatric Surgery","status":"UNKNOWN","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2023-04-21","conditions":["Anesthesia and Analgesia","Magnesium Sulfate","Bariatric Surgery Candidate"],"enrollment":104,"completionDate":"2024-06-30"},{"nctId":"NCT04307264","phase":"","title":"CHESS Criteria for Varices Screening in Compensated Advanced Chronic Liver Disease (CHESS2001/APPHA2001)","status":"COMPLETED","sponsor":"Hepatopancreatobiliary Surgery Institute of Gansu Province","startDate":"2020-03-18","conditions":["Compensated Advanced Chronic Liver Disease","Varices Needing Treatment"],"enrollment":2000,"completionDate":"2023-03-17"},{"nctId":"NCT03889756","phase":"PHASE2,PHASE3","title":"Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy","status":"TERMINATED","sponsor":"Yale University","startDate":"2019-07-17","conditions":["Major Depressive Disorder"],"enrollment":3,"completionDate":"2023-01-05"},{"nctId":"NCT01844726","phase":"PHASE2","title":"Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2013-05","conditions":["Psychiatric Illness","Healthy"],"enrollment":44,"completionDate":"2016-01"},{"nctId":"NCT05568316","phase":"NA","title":"Impact of Immunonutrition on Nutritional Status in Colorectal Cancer Patients","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2020-11-01","conditions":["Colorectal Cancer"],"enrollment":50,"completionDate":"2022-02-10"},{"nctId":"NCT05597241","phase":"PHASE1","title":"Multiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy Volunteers","status":"COMPLETED","sponsor":"Syndeio Biosciences, Inc","startDate":"2022-10-15","conditions":["Major Depressive Disorder"],"enrollment":40,"completionDate":"2023-04-04"},{"nctId":"NCT03596684","phase":"NA","title":"Citrulline Efficacy to Improve Carbohydrate Metabolism Abnormalities in the Patient Treated With High Doses of Statin","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2020-02-26","conditions":["Atorvastatin"],"enrollment":2,"completionDate":"2022-06-07"},{"nctId":"NCT05778461","phase":"NA","title":"Efficacy of L-ornithine L-aspartate and Therapeutic Plasma Exchange Versus Plasma Exchange Alone in Lowering Ammonia and Improving Outcomes in Pediatric Acute Liver Failure.","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2023-03-15","conditions":["Liver Failure, Acute"],"enrollment":32,"completionDate":"2024-10-30"},{"nctId":"NCT05227716","phase":"PHASE4","title":"Clinical Response to Magnesium Sulfate as an Adjunct in the Anesthesia","status":"UNKNOWN","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2022-10-01","conditions":["Anesthesia and Analgesia","Magnesium Sulfate"],"enrollment":104,"completionDate":"2024-07-31"},{"nctId":"NCT05691036","phase":"","title":"Bile Acids Metabolism and Genetic Mutation Profile in the ICP in the Indian Population","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2022-12-08","conditions":["Intrahepatic Cholestasis of Pregnancy","Genetic Mutation","Health Related Quality of Life"],"enrollment":150,"completionDate":"2025-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Capsule","formulations":[{"form":"CAPSULE, GELATIN COATED","route":"ORAL","productName":"Dermamed Nutrition for troubled skin"}]},"crossReferences":{"NUI":"N0000182443","MMSL":"d05397","NDDF":"003851","UNII":"R17X820ROL","VUID":"4030488","VANDF":"4030488","RXNORM":"142131","UMLSCUI":"C0543448","ChEMBL_ID":"CHEMBL2109228","DRUGBANK_ID":"DB13359","PUBCHEM_CID":"87869","SNOMEDCT_US":"421128005","SECONDARY_CAS_RN":"7018-07-7","MESH_DESCRIPTOR_UI":"D001224"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":160,"therapeuticAreas":["Gastroenterology"],"atcClassification":{"source":"DrugCentral","atcCode":"A12CC05","allCodes":["A12CC05"]},"biosimilarFilings":[],"recentPublications":[{"date":"2025 Nov","pmid":"41221788","title":"Single Center, Open-Label, Randomized Crossover Trial on Drug-Drug Interactions of Levothyroxine/Magnesium-Citrate and Levothyroxine/Magnesium-Aspartate in Healthy Subjects-The ThyroMag Trial.","journal":"Clinical and translational science"},{"date":"2025 Jan 10","pmid":"39792715","title":"Gitelman syndrome with diabetes and kidney stones: A case report.","journal":"Medicine"},{"date":"2024 Jul 22","pmid":"39062445","title":"In Males with Adequate Dietary Needs Who Present No Sleep Disturbances, Is an Acute Intake of Zinc Magnesium Aspartate, Following Either Two Consecutive Nights of 8 or 4 h of Sleep Deprivation, Beneficial for Sleep and Morning Stroop Interference Performance?","journal":"Behavioral sciences (Basel, Switzerland)"},{"date":"2024 Sep 4","pmid":"38639324","title":"Verifying the nonreporting hemolysis index for potassium, phosphate, magnesium, AST, LDH, iron, CA 19-9, and vitamin D, using Beckman Coulter AU5800 and DxI800 automated analyzers.","journal":"Laboratory medicine"},{"date":"2024 Apr 12","pmid":"38608089","title":"Clinical and genetic analysis of a case of Gitelman syndrome accompanied with Graves disease and adrenocortical adenoma: A case report.","journal":"Medicine"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Magnesium Hydroaspartate, also known as magnesium aspartate, is a small molecule drug in the magnesium aspartate class. It is used to treat various gastrointestinal conditions, including constipation, indigestion, and hypomagnesemia. The commercial status of Magnesium Hydroaspartate is unknown, but it is likely available as a generic medication. Key safety considerations include potential gastrointestinal side effects and interactions with other medications. Further research is needed to fully understand its pharmacokinetics and pharmacodynamics.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}